All Stories

  1. Neuroprotective Role of Quercetin against Alpha-Synuclein-Associated Hallmarks in Parkinson’s Disease
  2. Impact of Type 2 Diabetes Mellitus with a Focus on Asian Indians Living in India and Abroad: A Systematic Review
  3. Link of BIN1, CLU, and IDE Gene Polymorphisms with the Susceptibility of Alzheimer’s Disease: Evidence from a Meta-analysis
  4. Exploring the Role of Monoamine Oxidase Activity in Aging and Alzheimer’s Disease
  5. Nano-Neurotherapeutics (NNTs): An Emergent and Multifaceted Tool for CNS Disorders
  6. A Novel Nanoformulation of Ellagic Acid is Promising in Restoring Oxidative Homeostasis in Rat Brains with Alzheimer’s Disease
  7. Hutchinson-Gilford Progeria Syndrome: An Overview of the Molecular Mechanism, Pathophysiology and Therapeutic Approach
  8. Recent Advances in Synaptosomal Proteomics in Alzheimer’s Disease
  9. Synaptotagmin-1: A Multi-Functional Protein that Mediates Vesicle Docking, Priming, and Fusion
  10. Neuroproteomics on the Rise (Part II)
  11. Exploring Potential of Alkaloidal Phytochemicals Targeting Neuroinflammatory Signaling of Alzheimer's Disease
  12. Anti-Neuroinflammatory Potential of Polyphenols by Inhibiting NF-κB to Halt Alzheimer's Disease
  13. Challenges of Gene Therapy for Neurodegenerative Disorders
  14. Standardizing the Effective Correlated Dosage of Olanzapine and Empagliflozin in Female Wistar Rats
  15. Molecular Genetics of Early- and Late-Onset Alzheimer’s Disease
  16. Gene Therapy for Neuroprotection and Neurorestoration-Part III
  17. Emerging Promise of Nanoparticle-Based Treatment for Parkinson’s Disease
  18. Exploring the Anti-Neuroinflammatory Potential of Steroid and Terpenoid-Derived Phytochemicals to Combat Alzheimer's Disease
  19. Sleep Disturbances and Cognitive Impairment in the Course of Type 2 Diabetes-A Possible Link
  20. Molecular Insight into the Crosstalk of UPS Components and Alzheimer’s Disease
  21. Anti COVID19 Natural Compounds.
  22. Suicide and Suicide Attempts in the Elderly Patients: An Epidemiological Analysis of Risk Factors and Prevention
  23. Exploring the Multifunctional Neuroprotective Promise of Rasagiline Derivatives for Multi-Dysfunctional Alzheimer’s Disease
  24. A Study on Serological Reactivity Profile of Different Antigen Preparations with Bancroftian filariasis Human Infection Sera
  25. Evidence Linking Protein Misfolding to Quality Control in Progressive Neurodegenerative Diseases
  26. Promising Anti-stroke Signature of Voglibose: Investigation through In- Silico Molecular Docking and Virtual Screening in In-Vivo Animal Studies
  27. Gene Therapy for Neuroprotection and Neurorestoration (Part II)
  28. Emerging Promise of Immunotherapy for Alzheimer’s Disease: A New Hope for the Development of Alzheimer’s Vaccine
  29. Gene Therapy for Neuroprotection and Neurorestoration (Part I)
  30. Human papillomavirus induced Cervical and Oropharyngeal Cancers: From Mechanisms to Potential Immuno-Therapeutic Strategies
  31. ASK1 and its role in cardiovascular and other disorders: available treatments and future prospects
  32. Assessment of Psychosocial Functioning of Mothers of Children with Diabetes Mellitus Compared to Mothers of Healthy Children
  33. Lead Optimization Resources in Drug Discovery for Diabetes
  34. Quality of Life and Social Support in Women with Urinary Incontinence
  35. Natural compounds can be used for Alzheimer's and Parkinson's diseases treatment
  36. Preventive and Therapeutic Potentials of Anthocyanins in Diabetes and Associated Complications
  37. Essential Oils: Extraction Techniques, Pharmaceutical And Therapeutic Potential - A Review
  38. Cerebrospinal Fluid, Brain Electrolytes Balance, and the Unsuspected Intrinsic Property of Melanin to Dissociate the Water Molecule
  39. Nanoparticle-Based Drugs: A Potential Armamentarium of Effective Anti-Cancer Therapies
  40. Relationship between CNS and Immunology: Correlation with Psychology
  41. Advanced Glycation End Products (AGEs), Glutathione and Breast Cancer: Factors, Mechanism and Therapeutic Interventions
  42. A Synopsis on the Role of Human Papilloma Virus Infection in Cervical Cancer
  43. Editorial: New Emerging Trends in Protein and Peptide Based Therapeutic Approaches - Part II
  44. Impact of Hydroxyl Radical Modified-Human Serum Albumin Autoantigens in Systemic Lupus Erythematosus
  45. Mitochondrial Dynamics and Proteins Related to Neurodegenerative Diseases
  46. Proteins Commonly Linked to Autism Spectrum Disorder and Alzheimer's Disease
  47. New Emerging Trends in Protein and Peptide Based Therapeutic Approaches – Part I
  48. Frontier View on Nanotechnological Strategies for Neuro-therapy
  49. Potentiating Effect of Ethnomedicinal Plants Against Proliferation on Different Cancer Cell Lines
  50. The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo
  51. Chemosensitizing Activity of Histone Deacetylases Inhibitory Cyclic Hydroxamic Acids for Combination Chemotherapy of Lymphatic Leukemia
  52. Pharmacological Aspects of Neuro-Immune Interactions
  53. A Clinical Update and Global Economic Burden of Rheumatoid Arthritis
  54. Diabetes Mellitus and Male Aging: Pharmacotherapeutics and Clinical Implications
  55. PeMtb: A Database of MHC Antigenic Peptide of Mycobacterium tuberculosis
  56. Graphene Oxide based metallic nanoparticles and their some biological and environmental application
  57. Synopsis on Managment Strategies for Neurodegenerative Disorders: Challenges from Bench to Bedside in Successful Drug Discovery and Development
  58. Phage Display Technique: A Novel Medicinal Approach to Overcome An tibiotic Resistance by Using Peptide-Based Inhibitors Against β-Lactamases
  59. Recent Advances in Drug Delivery of Polymeric Nano-Micelles
  60. Therapeutic proteins
  61. Linkage of Stress with Neuromuscular Disorders
  62. Recent updates on the dynamic association between oxidative stress and neurodegenerative disorders
  63. A synopsis on the linkage between age-related dementias and vascular disorders
  64. Molecular Mechanisms of Drug Photodegradation and Photosensitization
  65. Super aggregated form of Amphotericin B: a novel way to increase its therapeutic index
  66. A proteomics based approach for the identification of gastric cancer related markers
  67. Chronic unpredictable stress deteriorates the chemopreventive efficacy of pomegranate through oxidative stress pathway
  68. Application of Efficient Nanoparticles for Early Diagnosis and Treatment of Cancer
  69. Applications of Nanotechnology in Diagnostics and Therapeutics of AD and PD
  70. An Overview on Global Trends in Nanotechnological Approaches for Alzheimer Therapy
  71. Therapeutic Interventions for the Suppression of Alzheimer’s Disease: Quest for a Remedy
  72. Application of Proteomic Tools in Modern Nanotechnological Approaches Towards Effective Management of Neurodegenerative Disorders
  73. Integrating Qualitative and Quantitative Tools for the Detection and Identification of Lectins in Major Human Diseases
  74. Chronic unpredictable stress (CUS) enhances the carcinogenic potential of 7,12-dimethylbenz(a)anthracene (DMBA) and accelerates the onset of tumor development in Swiss albino mice
  75. Biological Activities of QIAPI 1 as a Melanin Precursor and Its Therapeutic Effects in Wistar Rats Exposed to Arsenic Poisoning
  76. Reno-protective effect of garlic extract against immobilization stress induced changes in rats
  77. Beyond Mitochondria, What Would be the Energy Source of the Cell?
  78. Reduction of post-prandial hyperglycemia by mulberry tea in type-2 diabetes patients
  79. Studies on the role of goat heart galectin-1 as a tool for detecting post-malignant changes in glycosylation pattern
  80. Studies on the role of goat heart galectin-1 as an erythrocyte membrane perturbing agent
  81. Current Challenges to Overcome in the Management of Type 2 Diabetes Mellitus and Associated Neurological Disorders
  82. Synopsis on the Linkage of Alzheimer's and Parkinson's Disease with Chronic Diseases
  83. Pro-oxidant DNA Breakage Induced by the Interaction of L-DOPA with Cu(II): A Putative Mechanism of Neurotoxicity
  84. Altered Galectin Glycosylation: Potential Factor for the Diagnostics and Therapeutics of Various Cardiovascular and Neurological Disorders
  85. Protein Misfolding and Aggregation in Alzheimer’s Disease and Type 2 Diabetes Mellitus
  86. Proteomics Approaches to Understand Linkage Between Alzheimer’s Disease and Type 2 Diabetes Mellitus
  87. A Region-specific Treatment Strategy To Address The Problem Of Drug Resistance By NDM-1-producing Pathogens
  88. Cancer Chemoprevention by Polyphenols and Their Potential Application as Nanomedicine
  89. Novel Ocimum sanctum compounds modulate stress response: Role of CRF, POMC, GR and HSP-70 in the hypothalamus and pituitary of rats
  90. Nanotechnology-based approaches in anticancer research
  91. Brain Region Specific Monoamine and Oxidative Changes During Restraint Stress
  92. Novel Ocimumoside A and B as anti-stress agents: Modulation of brain monoamines and antioxidant systems in chronic unpredictable stress model in rats
  93. A comparative study of support vector machine, artificial neural network and Bayesian classifier for mutagenicity prediction
  94. Purification, Characterization, Sequencing and Biological Chemistry of Galectin-1 Purified from Capra hircus (goat) Heart
  95. Implication of Oxidative Stress-Induced Oncogenic Signaling Pathways as a Treatment Strategy for Neurodegeneration and Cancer
  96. Potential Preventive Effects of Coenzyme Q and Creatine Supplementation on Brain Energy Metabolism in Rats Exposed to Chronic Cerebral Hypoperfusion
  97. Multivitamin–Mineral and Vitamins (E + C) Supplementation Modulate Chronic Unpredictable Stress-Induced Oxidative Damage in Brain and Heart of Mice
  98. Purification, characterization, structural analysis and protein chemistry of a buffalo heart galectin-1
  99. The Three-Vessel Occlusion as a Model of Vascular Dementia – Oxidative Stress and Mitochondrial Failure as an Indicator of Brain Hypoperfusion
  100. Galectins – Potential targets for cancer therapy